PTGX
PTGX
$139.54
per share, on-chain
What PTGX does
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
- Industry
- Healthcare
- Website
- protagonist-inc.com
Ways to own PTGX
There's one version of this stock on Firstshare.
OndoPTGXonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
$139.54
Closed until New York opens
Price check
What a slice looks like
$10.00 buys you 0.072 of one PTGX share.
That's 7.2% of one share. Small, but it's yours, and it moves with the real price. One share costs $139.54.